中國能建(601868.SH):正籌劃非公開發行A股股票事項
格隆匯10月23日丨中國能建(601868.SH)公佈,為助力公司“30·60”戰略目標落地,構築新能源、新基建、新產業“三新”發展平台,公司正在籌劃非公開發行A股股票事項,擬將募集資金用於以新能源為主的新型綜合能源項目,包括光伏、風電、氫能、儲能等新能源一體化、專業化項目,新能源工程施工項目、新能源重大裝備採購,以及生態環境治理、新型基礎設施等項目。此次募集資金總額在人民幣150億元以內。此次非公開發行股票方案最終以經公司董事會、股東大會批准及國務院國資委批覆、公司證券上市地的證券監管機構核准的方案為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.